1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2

Journal of Medicinal Chemistry
I K KhannaP C Isakson

Abstract

Series of 1,2-diarylpyrroles has been synthesized and found to contain very potent and selective inhibitors of the human cyclooxygenase-2 (COX-2) enzyme. The paper describes short and practical syntheses of the target molecules utilizing the Paal-Knorr reaction. Electrophilic substitution on 1 proceeds in a regioselective fashion, and the method was used to generate a number of tetrasubstituted pyrroles. Detailed SAR on the series has been studied by modifications of the aryl rings and the substituents in the pyrrole ring. Diarylpyrrole 1 is a very potent (COX-2, IC50 = 60 nm) and selective (COX-1/COX-2 = > 1700) inhibitor whereas the isomeric 2 is completely inactive against COX-2. Modifications of the substituents on the fluorophenyl ring in 1 yields very potent inhibitors of COX-2 (IC50 = 40-80 nm) with excellent selectivity (1200 to > 2500) vs COX-1. Analog 20 containing a sulfonamide group is an excellent inhibitor of COX-2 with an IC50 of 14 nm. Tetrasubstituted pyrroles containing groups such as COCF3, SO2CF3, or CH2OAr at position 3 in the pyrrole ring give excellent inhibitors (COX-2, IC50 = 30-120 nm). In vivo testing in the carrageenan-induced paw edema model in the rat establishes that the 1,2-diarylpyrroles are ora...Continue Reading

References

Sep 10, 1992·The New England Journal of Medicine·M C AllisonR I Russell
Jul 1, 1987·Kidney International·C Patrono, M J Dunn
Aug 15, 1972·Experientia·K TanakaH Masuda
Jun 23, 1971·Nature: New Biology·J B Smith, A L Willis
Sep 29, 1995·Journal of Medicinal Chemistry·W W WilkersonJ M Trzaskos
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·K SeibertP Isakson
Apr 1, 1994·Journal of Medicinal Chemistry·W W WilkersonN Wong
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L MasferrerK Seibert
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A MitchellJ R Vane
Feb 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C BrideauC C Chan
Dec 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·C A WINTERG W NUSS

❮ Previous
Next ❯

Citations

Dec 4, 2003·Bioorganic & Medicinal Chemistry·Wenhui HuGuifang Cheng
Mar 17, 2004·Bioorganic & Medicinal Chemistry·Mariangela BiavaFabrizio Manetti
Jul 12, 2000·European Journal of Medicinal Chemistry·G DannhardtB Fiebich
May 6, 2003·Bioorganic & Medicinal Chemistry Letters·Manojit PalKoteswar Rao Yeleswarapu
Sep 16, 1998·Current Opinion in Chemical Biology·L J Marnett, A S Kalgutkar
Nov 11, 1999·British Journal of Pharmacology·F NantelC C Chan
Oct 3, 2013·International Journal of Molecular Sciences·Kousuke KumagaiYoshitaka Matsusue
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Oct 28, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bandapalli Palakshi ReddyNaif Abdullah Al-Dhabi
Nov 9, 2004·Journal of Molecular Graphics & Modelling·Prasanna A Datar, Evans C Coutinho
May 27, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Rafia BashirKalim Javed
May 5, 2001·Expert Opinion on Pharmacotherapy·N M DaviesM A de Leeuw
Feb 24, 2015·Journal of Cheminformatics·Isidro Cortes-CirianoThérèse E Malliavin
Sep 3, 2013·European Journal of Medicinal Chemistry·Donatella BoschiAlberto Gasco
Jun 17, 2006·Bioorganic & Medicinal Chemistry Letters·Kimberly G PetrovKaren E Lackey
Mar 1, 2006·Bioorganic & Medicinal Chemistry Letters·Adrian HallRichard J Wilson
Oct 1, 2011·Archiv der Pharmazie·Mosaad S MohamedSamar S Fathallah
Oct 3, 2018·SAR and QSAR in Environmental Research·Y XiA Yan
Jun 5, 2010·Organic & Biomolecular Chemistry·Alexander V ButinGennady D Krapivin
Mar 23, 2011·Journal of Heterocyclic Chemistry·Bereket MochonaKinfe K Redda
Dec 25, 2009·Journal of Enzyme Inhibition and Medicinal Chemistry·Seref DemirayakRana Aslan
Jan 12, 2021·Journal of Biomolecular Structure & Dynamics·Josiane V CruzCleydson B R Santos
Apr 24, 2009·Chemical Reviews·Nuno R CandeiasAlexandre F Trindade
Mar 13, 2003·Chemical Reviews·Rajni GargCorwin Hansch
Jun 2, 2021·Chembiochem : a European Journal of Chemical Biology·Sachin B WaghAlexander Kornienko
Jan 1, 2020·RSC Advances·Sachin B WaghAlexander Kornienko
Feb 15, 2019·Journal of Chemical Information and Modeling·Zijian QinAixia Yan
Nov 14, 2000·The Journal of Organic Chemistry·A R KatritzkyO V Denisko
Sep 6, 2011·Bioorganic & Medicinal Chemistry Letters·M Abdur RahimEdward E Knaus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.